Ticker · CUSIP 53220K504

LGND

LIGAND PHARMACEUTICALS INC
···Share
Holders (tracked)
10
Combined shares
225,758
Combined value
$42.68M
Last close
$231.82
Quarter
2025Q4
Price · 1Y$231.82+126.85 (+120.84%)H $232.34 · L $100.19 · Avg Vol 201K
Congress buy
$100.00$150.00$200.00VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
10112024Q12025Q4
Price is +22.6% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

17 events
  1. +574 shares · 2025Q4
    Position
  2. −11,246 shares · 2025Q4
    Position
  3. +110 shares · 2025Q4
    Position
  4. +19,037 shares · 2025Q4
    Position
  5. −16,700 shares · 2025Q4
    Position
  6. +1,077 shares · 2025Q4
    Position
  7. +2,919 shares · 2025Q4
    Position
  8. +21,932 shares · 2025Q4
    Position
  9. +1,226 shares · 2025Q3
    Position
  10. +16,700 shares · 2025Q3
    Position
  11. +10,363 shares · 2025Q3
    Position
  12. +947 shares · 2025Q3
    Position
  13. +946 shares · 2025Q3
    Position
  14. −14,073 shares · 2025Q3
    Position
  15. +1,288 shares · 2025Q3
    Position
  16. +2,860 shares · 2025Q3
    Position
  17. −18,144 shares · 2024Q3
    Position

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of LGND…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2016Q1$110.99+108.9%$4.6M
Ken Fisher (Fisher Asset Mgmt)2016Q1$111.82+107.3%$30.3M
AQR Capital Management2016Q1$114.67+102.2%$1.2M
Wellington Management2017Q2$127.25+82.2%$2.0M
Ken Griffin (Citadel Advisors)2016Q3$173.30+33.8%$811K
Ken Griffin (Citadel Advisors)2016Q3$173.30+33.8%$811K
Ken Griffin (Citadel Advisors)2016Q3$173.30+33.8%$811K
D.E. Shaw & Co.2016Q1$184.51+25.6%$8.5M
D.E. Shaw & Co.2016Q1$184.51+25.6%$8.5M
Ray Dalio (Bridgewater Associates)2025Q3$185.42+25.0%$975K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions0
Trimmed1
Exited1

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
10
$14.52B
2022Q2
11
$11.12B
2022Q3
11
$279.3M
2022Q4
13
$234.6M
2023Q1
14
$241.7M
2023Q2
11
$232.5M
2023Q3
12
$199.2M
2023Q4
11
$235.7M
2024Q1
11
$235.7M
2024Q2
12
$265.6M
2024Q3
9
$18.6M
2024Q4
6
$19.6M
2025Q1
8
$15.5M
2025Q2
8
$22.9M
2025Q3
10
$35.1M
2025Q4
10
$42.7M
Congress members trading this stock
DateMemberTypeAmount rangeFiling
2026-03-03Gilbert CisnerosBuy$1K – $15KPDF ↗
2026-01-15Gilbert CisnerosBuy$1K – $15KPDF ↗
2026-01-05Gilbert CisnerosBuy$1K – $15KPDF ↗

Who owns LGND

10 super-investors · 2025Q4
Tracked stake
225.8K
shares
Combined value
$43M
% of shares outstanding
shares-out unknown
Quarter action mix
Added7Trim3
#ManagerSharesValue
1Ken Fisher
Fisher Asset Mgmt
130.9K$25M
2D.E. Shaw & Co.36.6K$7M
3T. Rowe Price20.0K$4M
4Wellington Management8.4K$2M
5D.E. Shaw & Co.7.6K$1M
6Ken Griffin
Citadel Advisors
7.4K$1M
7AQR Capital Management5.2K$975K
8Ray Dalio
Bridgewater Associates
4.2K$795K
9Ken Griffin
Citadel Advisors
3.5K$662K
10Ken Griffin
Citadel Advisors
2.1K$391K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live LGND chart.
<iframe src="https://openstocks.me/embed/stocks/LGND" width="100%" height="480" frameborder="0" loading="lazy" title="LGND chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Explore related topics